サマリー

スルホンアミドの世界市場 2022-2026 年
Technavioはスルホンアミド市場を監視しており、2022-2026年の間に1億2842万ドルの成長が見込まれ、予測期間中にCAGR 4.68%で加速しています。当レポートでは、スルホンアミド市場の全体分析、市場規模と予測、動向、成長促進要因、課題、さらに約25社のベンダーを網羅したベンダー分析などを提供しています。
現在の世界市場のシナリオ、最新のトレンドとドライバー、市場全体の環境について最新の分析を提供しています。市場は、感染症の流行、個人の尿路感染症の増加、特別な規制の指定によって牽引されています。
スルフォンアミド市場の分析には、製剤セグメントと地理的状況が含まれます。
Technavioのスルフォンアミド市場は、以下のように区分されています。
製剤別
- 経口剤
- 外用剤
地理的状況別
- 北アメリカ
- 欧州
- APAC
- 南米
- 中東・アフリカ
本研究では、今後数年間におけるスルホンアミド市場の成長を促進する主な理由の1つとして、さまざまな疾患とその治療に対する意識の高まりを挙げています。また、戦略的提携や合併・買収（M&A）、抗生物質研究のための連邦政府や機関投資家の資金提供の増加が、市場の大きな需要につながるとしています。
Technavio社は、複数のソースからのデータを調査、合成、要約する方法で、主要パラメータの分析により、市場の詳細な姿を提示します。スルホンアミド市場に関する弊社のレポートは、以下の分野を対象としています。
- スルホンアミド市場のサイジング
- スルホンアミド市場の予測
- スルホンアミド市場の産業分析
Technavioの強力なベンダー分析は、お客様が市場での地位を向上できるように設計されており、これに沿って本レポートでは、AA Pharma Inc.、Abbott Laboratories、Agron Remedies Pvt.Ltd. 、Amneal Pharmaceuticals Inc.、 C. H. Boehringer Sohn AG, and Co.KG、Cadila Pharmaceuticals Ltd.、Cipla Ltd.、Dhanuka Agritech Ltd.、F. Hoffmann La Roche Ltd.、GlaxoSmithKline Plc、Lexine Technochem Pvt.Ltd. 、Novartis AG、PANPHARMA S.A、Pfizer Inc、Sanofi、Smilax Laboratories Ltd. 、Stedman Pharmaceuticals Pvt.Ltd, Teva Pharmaceutical Industries Ltd, Viatris Inc、およびZydus Lifesciences Ltd. などのメーカーがあります。また、スルホンアミド市場の分析レポートには、今後の動向や市場成長に影響を与える課題に関する情報も含まれています。これは、企業が今後訪れるすべての成長機会を戦略的に活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む一次情報および二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/sulphonamides-market-industry-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数のソースからのデータの研究、合成、総括の方法により、市場の詳細な姿を提示します。また、業界の主要なインフルエンサーを特定することにより、市場の様々な側面を提示します。提示されるデータは、包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Formulation
o Exhibit 06: Executive Summary - Chart on Incremental Growth
o Exhibit 07: Executive Summary - Data Table on Incremental Growth
o Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
• 5 Market Segmentation by Formulation
o 5.1 Market segments
o Exhibit 24: Chart on Formulation - Market share 2021-2026 (%)
o Exhibit 25: Data Table on Formulation - Market share 2021-2026 (%)
o 5.2 Comparison by Formulation
o Exhibit 26: Chart on Comparison by Formulation
o Exhibit 27: Data Table on Comparison by Formulation
o 5.3 Oral - Market size and forecast 2021-2026
o Exhibit 28: Chart on Oral - Market size and forecast 2021-2026 ($ million)
o Exhibit 29: Data Table on Oral - Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Chart on Oral - Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on Oral - Year-over-year growth 2021-2026 (%)
o 5.4 Topical - Market size and forecast 2021-2026
o Exhibit 32: Chart on Topical - Market size and forecast 2021-2026 ($ million)
o Exhibit 33: Data Table on Topical - Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Chart on Topical - Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on Topical - Year-over-year growth 2021-2026 (%)
o 5.5 Market opportunity by Formulation
o Exhibit 36: Market opportunity by Formulation ($ million)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
o Exhibit 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 40: Chart on Geographic comparison
o Exhibit 41: Data Table on Geographic comparison
o 7.3 North America - Market size and forecast 2021-2026
o Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
o Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
o 7.4 Europe - Market size and forecast 2021-2026
o Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
o Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
o 7.5 APAC - Market size and forecast 2021-2026
o Exhibit 50: Chart on APAC - Market size and forecast 2021-2026 ($ million)
o Exhibit 51: Data Table on APAC - Market size and forecast 2021-2026 ($ million)
o Exhibit 52: Chart on APAC - Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on APAC - Year-over-year growth 2021-2026 (%)
o 7.6 South America - Market size and forecast 2021-2026
o Exhibit 54: Chart on South America - Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on South America - Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on South America - Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on South America - Year-over-year growth 2021-2026 (%)
o 7.7 Middle East and Africa - Market size and forecast 2021-2026
o Exhibit 58: Chart on Middle East and Africa - Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on Middle East and Africa - Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on Middle East and Africa - Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on Middle East and Africa - Year-over-year growth 2021-2026 (%)
o 7.8 US - Market size and forecast 2021-2026
o Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)
o 7.9 China - Market size and forecast 2021-2026
o Exhibit 66: Chart on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 67: Data Table on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 68: Chart on China - Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on China - Year-over-year growth 2021-2026 (%)
o 7.10 Germany - Market size and forecast 2021-2026
o Exhibit 70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 72: Chart on Germany - Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
o 7.11 France - Market size and forecast 2021-2026
o Exhibit 74: Chart on France - Market size and forecast 2021-2026 ($ million)
o Exhibit 75: Data Table on France - Market size and forecast 2021-2026 ($ million)
o Exhibit 76: Chart on France - Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on France - Year-over-year growth 2021-2026 (%)
o 7.12 Canada - Market size and forecast 2021-2026
o Exhibit 78: Chart on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 79: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 80: Chart on Canada - Year-over-year growth 2021-2026 (%)
o Exhibit 81: Data Table on Canada - Year-over-year growth 2021-2026 (%)
o 7.13 Japan - Market size and forecast 2021-2026
o Exhibit 82: Chart on Japan - Market size and forecast 2021-2026 ($ million)
o Exhibit 83: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
o Exhibit 84: Chart on Japan - Year-over-year growth 2021-2026 (%)
o Exhibit 85: Data Table on Japan - Year-over-year growth 2021-2026 (%)
o 7.14 Market opportunity By Geographical Landscape
o Exhibit 86: Market opportunity By Geographical Landscape ($ million)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 87: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 88: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 89: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 90: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 91: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 92: Matrix on vendor position and classification
o 10.3 AA Pharma Inc.
o Exhibit 93: AA Pharma Inc. - Overview
o Exhibit 94: AA Pharma Inc. - Product / Service
o Exhibit 95: AA Pharma Inc. - Key offerings
o 10.4 Abbott Laboratories
o Exhibit 96: Abbott Laboratories - Overview
o Exhibit 97: Abbott Laboratories - Business segments
o Exhibit 98: Abbott Laboratories - Key offerings
o Exhibit 99: Abbott Laboratories - Segment focus
o 10.5 F. Hoffmann La Roche Ltd.
o Exhibit 100: F. Hoffmann La Roche Ltd. - Overview
o Exhibit 101: F. Hoffmann La Roche Ltd. - Business segments
o Exhibit 102: F. Hoffmann La Roche Ltd. - Key news
o Exhibit 103: F. Hoffmann La Roche Ltd. - Key offerings
o Exhibit 104: F. Hoffmann La Roche Ltd. - Segment focus
o 10.6 GlaxoSmithKline Plc
o Exhibit 105: GlaxoSmithKline Plc - Overview
o Exhibit 106: GlaxoSmithKline Plc - Business segments
o Exhibit 107: GlaxoSmithKline Plc - Key news
o Exhibit 108: GlaxoSmithKline Plc - Key offerings
o Exhibit 109: GlaxoSmithKline Plc - Segment focus
o 10.7 Lexine Technochem Pvt. Ltd.
o Exhibit 110: Lexine Technochem Pvt. Ltd. - Overview
o Exhibit 111: Lexine Technochem Pvt. Ltd. - Product / Service
o Exhibit 112: Lexine Technochem Pvt. Ltd. - Key offerings
o 10.8 Novartis AG
o Exhibit 113: Novartis AG - Overview
o Exhibit 114: Novartis AG - Business segments
o Exhibit 115: Novartis AG - Key offerings
o Exhibit 116: Novartis AG - Segment focus
o 10.9 Pfizer Inc.
o Exhibit 117: Pfizer Inc. - Overview
o Exhibit 118: Pfizer Inc. - Product / Service
o Exhibit 119: Pfizer Inc. - Key news
o Exhibit 120: Pfizer Inc. - Key offerings
o 10.10 Sanofi
o Exhibit 121: Sanofi - Overview
o Exhibit 122: Sanofi - Business segments
o Exhibit 123: Sanofi - Key news
o Exhibit 124: Sanofi - Key offerings
o Exhibit 125: Sanofi - Segment focus
o 10.11 Teva Pharmaceutical Industries Ltd.
o Exhibit 126: Teva Pharmaceutical Industries Ltd. - Overview
o Exhibit 127: Teva Pharmaceutical Industries Ltd. - Business segments
o Exhibit 128: Teva Pharmaceutical Industries Ltd. - Key news
o Exhibit 129: Teva Pharmaceutical Industries Ltd. - Key offerings
o Exhibit 130: Teva Pharmaceutical Industries Ltd. - Segment focus
o 10.12 Viatris Inc.
o Exhibit 131: Viatris Inc. - Overview
o Exhibit 132: Viatris Inc. - Business segments
o Exhibit 133: Viatris Inc. - Key offerings
o Exhibit 134: Viatris Inc. - Segment focus
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 135: Inclusions checklist
o Exhibit 136: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 137: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 138: Research methodology
o Exhibit 139: Validation techniques employed for market sizing
o Exhibit 140: Information sources
o 11.5 List of abbreviations
o Exhibit 141: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Formulation
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between 2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Formulation - Market share 2021-2026 (%)
Exhibits25: Data Table on Formulation - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Formulation
Exhibits27: Data Table on Comparison by Formulation
Exhibits28: Chart on Oral - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Oral - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Oral - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Oral - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Topical - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Topical - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Topical - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Topical - Year-over-year growth 2021-2026 (%)
Exhibits36: Market opportunity by Formulation ($ million)
Exhibits37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits38: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits40: Chart on Geographic comparison
Exhibits41: Data Table on Geographic comparison
Exhibits42: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits45: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on APAC - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on APAC - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on APAC - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on APAC - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on South America - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on South America - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on South America - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on South America - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on Middle East and Africa - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on Middle East and Africa - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on Middle East and Africa - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on Middle East and Africa - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on France - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on France - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on France - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on France - Year-over-year growth 2021-2026 (%)
Exhibits78: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits79: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits80: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits81: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits82: Chart on Japan - Market size and forecast 2021-2026 ($ million)
Exhibits83: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
Exhibits84: Chart on Japan - Year-over-year growth 2021-2026 (%)
Exhibits85: Data Table on Japan - Year-over-year growth 2021-2026 (%)
Exhibits86: Market opportunity By Geographical Landscape ($ million)
Exhibits87: Impact of drivers and challenges in 2021 and 2026
Exhibits88: Overview on Criticality of inputs and Factors of differentiation
Exhibits89: Overview on factors of disruption
Exhibits90: Impact of key risks on business
Exhibits91: Vendors covered
Exhibits92: Matrix on vendor position and classification
Exhibits93: AA Pharma Inc. - Overview
Exhibits94: AA Pharma Inc. - Product / Service
Exhibits95: AA Pharma Inc. - Key offerings
Exhibits96: Abbott Laboratories - Overview
Exhibits97: Abbott Laboratories - Business segments
Exhibits98: Abbott Laboratories - Key offerings
Exhibits99: Abbott Laboratories - Segment focus
Exhibits100: F. Hoffmann La Roche Ltd. - Overview
Exhibits101: F. Hoffmann La Roche Ltd. - Business segments
Exhibits102: F. Hoffmann La Roche Ltd. - Key news
Exhibits103: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits104: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits105: GlaxoSmithKline Plc - Overview
Exhibits106: GlaxoSmithKline Plc - Business segments
Exhibits107: GlaxoSmithKline Plc - Key news
Exhibits108: GlaxoSmithKline Plc - Key offerings
Exhibits109: GlaxoSmithKline Plc - Segment focus
Exhibits110: Lexine Technochem Pvt. Ltd. - Overview
Exhibits111: Lexine Technochem Pvt. Ltd. - Product / Service
Exhibits112: Lexine Technochem Pvt. Ltd. - Key offerings
Exhibits113: Novartis AG - Overview
Exhibits114: Novartis AG - Business segments
Exhibits115: Novartis AG - Key offerings
Exhibits116: Novartis AG - Segment focus
Exhibits117: Pfizer Inc. - Overview
Exhibits118: Pfizer Inc. - Product / Service
Exhibits119: Pfizer Inc. - Key news
Exhibits120: Pfizer Inc. - Key offerings
Exhibits121: Sanofi - Overview
Exhibits122: Sanofi - Business segments
Exhibits123: Sanofi - Key news
Exhibits124: Sanofi - Key offerings
Exhibits125: Sanofi - Segment focus
Exhibits126: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits127: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits128: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits129: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits130: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits131: Viatris Inc. - Overview
Exhibits132: Viatris Inc. - Business segments
Exhibits133: Viatris Inc. - Key offerings
Exhibits134: Viatris Inc. - Segment focus
Exhibits135: Inclusions checklist
Exhibits136: Exclusions checklist
Exhibits137: Currency conversion rates for US$
Exhibits138: Research methodology
Exhibits139: Validation techniques employed for market sizing
Exhibits140: Information sources
Exhibits141: List of abbreviations